#USA #Irvine #Zymo Research #STORI #Cell-Free DNA

Advancements in Early Pregnancy Detection: A New Era in Women's Health

In an exciting development in the realm of women's health, Zymo Research has announced a pivotal partnership with STORI to introduce an innovative early pregnancy assay. This cutting-edge test facilitates the detection of placental-derived DNA in maternal blood as early as five weeks into gestation. The collaboration aims to provide a more accurate and timely solution for mothers-to-be, ensuring that they receive vital information about their pregnancy in its earliest stages.

Harnessing Molecular Biology
Utilizing state-of-the-art molecular biology techniques, the assay incorporates a carefully engineered workflow designed by Zymo Research. This advanced technology seamlessly integrates optimized sample preservation, cell-free DNA extraction chemistry, and intricate computational analysis. Each phase of the process has been meticulously crafted to ensure reliable recovery and detection of low-abundance circulating DNA fragments during the earliest moments of pregnancy.

Dr. Paolo Piatti, Director of Applied Epigenetics at Zymo Research, stated the challenge of identifying fetal DNA when the embryo is as minuscule as a poppy seed. He emphasized the need to reinvent various steps of the workflow in order to accurately capture these scarcely present signals, heralding new possibilities for sensitive circulating DNA analysis.

Transitioning to Accountability in Early Insights
The CEO of STORI, Sabina Melarti, reflected on the significance of early pregnancy assessments, noting the presence of crucial biological signals during these initial periods, though they can be challenging to measure accurately. She underscored the importance of not only obtaining an answer quicker but ensuring that it is delivered with the utmost precision and care. This collaboration will empower STORI to commercialize Zymo's technology, making it accessible to a wider audience through their reproductive health platform.

As part of their offering, this breakthrough assay will support at-home capillary blood collection, further democratizing access to early-stage pregnancy testing. One of the exciting potential applications includes prenatal biological sex determination, giving prospective parents additional insight into their pregnancy.

A Bright Future for Prenatal Care
Preliminary validations of the assay's analytical performance have shown promise, with further IRB-approved clinical studies currently in progress to enhance its characterization and gestational sensitivity. This initiative represents an important step forward in prenatal care by providing early confirmation of pregnancy, which can lead to better management and care during the critical first weeks.

About Zymo Research
Founded in 1994, Zymo Research has established itself as a trailblazer in the biotech landscape, offering highly effective molecular tools that address the complex challenges of life sciences. Their guiding principle is simple: “The Beauty of Science is to Make Things Simple.” As pioneers in epigenetics, Zymo Research focuses on a comprehensive array of technologies, including solutions for sample collection, DNA/RNA purification, and Next-Generation Sequencing (NGS) services. Besides these innovative technologies, the company is committed to sustainability, striving to create environmentally friendly solutions that contribute to a greener future.

About STORI
STORI, dedicated to furthering women's health, specializes in early human developmental biology. They enhance the understanding of molecular signals to provide accessible biological insights, ensuring scientific rigor alongside responsible, human-centered interpretations. Their focus spans the entire perinatal spectrum, supporting a healthy pathway from fertility to pregnancy and beyond.

As the partnership between Zymo Research and STORI unfolds, it promises to pave the way for future advancements in reproductive health and prenatal diagnostics, prioritizing early detection and empowering women on their motherhood journey.